// App-Quantinova.ai

AB0196 : ANTIBODIES VERSUS DOMAIN I OF BETA2-GLYCOPROTEIN I: A MARKER OF SYSTEMIC AUTOIMMUNITY?

Researchers

Presenter

  • C. Nalli

Principal Investigators

  • L. Andreoli

  • G. Norman

  • Z. Shums

  • S. Encabo

  • P.L. Meroni

  • A. Tincani

Medical Centers

  • Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy

  • Translational Medicine, University of Milan, Milan, Italy

Locations

  • Italy

Companies

  • Inova Diagnostics, I

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Antiphospholipid syndrome

  • Primary biliary cirrhosis

  • Ankylosing spondylitis

  • Rheumatoid arthritis

  • Scleroderma

  • Sjogren's syndrome

  • Coronary Artery Disease

  • Venous thrombosis

  • Cirrhosis

  • Inflammatory Arthritis

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim